Amifampridine firdapse 10MG tab
Ended Awarded Last action
- Contract number
- 36C26024F0017
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$203,148 | |
| Original award | $203,148 |
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a $203,147 delivery order to Catalyst Pharmaceuticals, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Catalyst Pharmaceuticals will supply AMIFAMPRIDINE FIRDAPSE 10MG tablets to various VA facilities in Veterans Integrated Service Network 20. Performance will take place in Bartlett, Tennessee over a one year base period from November 1, 2023 through October 31, 2024. Pricing is firm fixed. This delivery order supports the VA's mission to provide healthcare services to veterans by procuring a drug to treat Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.
Quick answers
Who was awarded contract 36C26024F0017?
36C26024F0017 was awarded to Catalyst Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2023.
How much is contract 36C26024F0017 worth?
The government has obligated $0 on 36C26024F0017.
Is contract 36C26024F0017 an order under another contract?
Yes. 36C26024F0017 is a delivery order under 36F79719D0160, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0017 competed?
The extent of competition for 36C26024F0017 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award